XNAS
WALDW
Market cap196mUSD
Jul 09, Last price
0.04USD
1D
-5.79%
1Q
25.17%
IPO
-94.16%
Name
Waldencast PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Waldencast plc operates as a specialized skincare enterprise, delivering sophisticated treatments aimed at improving various dermatological conditions. Its product offerings are crafted to minimize the visual impact of early aging, skin damage, uneven pigmentation, acne, and harm from sun exposure. These solutions are predominantly distributed through professional avenues such as dermatologists, plastic surgeons, medical spas, and other skincare professionals. The company's portfolio encompasses Obagi Medical, which provides groundbreaking skincare products designed to alleviate signs of skin aging, treat issues like dark spots, hyperpigmentation, and fine lines, while simultaneously protecting and enhancing skin's overall tone and texture. Additionally, its Obagi Clinical line features products specifically developed to stave off the initial indicators of skin aging. Founded in 1988, Waldencast plc is based in White Plains, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||